Viewing data from:

VASOCON

ANDA

NAPHAZOLINE HYDROCHLORIDE | A080235 | NOVARTIS PHARMACEUTICALS CORP

1 strength0 unique patents0 unique exclusivities

API Supply Chain4 active DMFs4 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

LOBA BIOTECH GMBHNAPHAZOLINE HYDROCHLORIDE

DMF 106671994

MICRO LABS LTDNAPHAZOLINE HYDROCHLORIDE USP

DMF 324652018

BIOPHORE INDIA PHARMACEUTICALS PVT LTDNAPHAZOLINE HYDROCHLORIDE

DMF 358332021

C-SQUARED PHARMA LTDNAPHAZOLINE HYDROCHLORIDE

DMF 406942024

CIBA GEIGY CORP PHARMACEUTICAL DIVInactiveNAPHAZOLINE HYDROCHLORIDE

DMF 97091992

FUKUZYU PHARMACEUTICAL CO LTDInactiveNAPHAZOLINE HYDROCHLORIDE

DMF 99341992

JOHNSON MATTHEY INCInactiveNAPHAZOLINE HYDROCHLORIDE

DMF 110661994

ALP PHARM BEIJING CO LTDInactiveNAPHAZOLINE HYDROCHLORIDE (DRUG SUBSTANCE, NON-STERILE)

DMF 236422010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#002 — 0.1%

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Mar 24, 1983

No patent or exclusivity listings for this strength.